XML 28 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Oct. 02, 2020
Sep. 27, 2019
Sep. 28, 2018
Income Statement [Abstract]      
Revenue $ 12,829,559 $ 16,227,341 $ 15,789,633
Costs and Expenses:      
Cost of services provided 11,993,667 14,532,662 13,997,911
Depreciation and amortization 595,195 592,573 596,182
Selling and general corporate expenses 307,016 367,256 377,129
Goodwill impairment 198,600 0 0
Gain on sale of Healthcare Technologies 0 (156,309) 0
Costs and Expenses 13,094,478 15,336,182 14,971,222
Operating (loss) income (264,919) 891,159 818,411
Interest and Other Financing Costs, net 382,800 334,987 346,535
(Loss) Income Before Income Taxes (647,719) 556,172 471,876
(Benefit) Provision for Income Taxes (186,284) 107,706 (96,564)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total (461,435) 448,466 568,440
Less: Net income (loss) attributable to noncontrolling interest 94 (83) 555
Net (loss) income attributable to Aramark stockholders $ (461,529) $ 448,549 $ 567,885
(Loss) Earnings per share attributable to Aramark stockholders:      
Basic (in dollars per share) $ (1.83) $ 1.82 $ 2.31
Diluted (in dollars per share) $ (1.83) $ 1.78 $ 2.24
Weighted Average Shares Outstanding:      
Basic (in shares) 251,828 246,854 245,771
Diluted (in shares) 251,828 252,010 253,352